(Q39888117)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189311%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

CTL induction by cross-priming is restricted to immunodominant epitopes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189311%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189311%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Viktor Pavelic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189311%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sabine Mumprecht

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189311%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Isabel Breyer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189311%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Adrian F Ochsenbein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189311%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

1 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189311%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189311%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189311%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189311%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

704-716

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189311%20AND%20SRC:MED&resulttype=core&format=json

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Fibroblasts as efficient antigen-presenting cells in lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Cross-presentation by intercellular peptide transfer through gap junctions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Recent advances in antigen processing and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Antigen bias in T cell cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Cellular protein is the source of cross-priming antigen in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

CD8+ T cell cross-priming via transfer of proteasome substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type I IFN and stabilization of class I MHC mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

CpG-DNA aided cross-presentation of soluble antigens by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

A listing of human tumor antigens recognized by T cells: March 2004 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Estimating the precursor frequency of naive antigen-specific CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Epitope dominance, competition and T cell affinity maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Feedback regulation of pathogen-specific T cell priming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Bystander elimination of antigen loss variants in established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

A lymphocytic choriomeningitis virus glycoprotein variant that is retained in the endoplasmic reticulum efficiently cross-primes CD8(+) T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Activation of Dendritic Cells That Cross-Present Tumor-Derived Antigen Licenses CD8+ CTL to Cause Tumor Eradication

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2FEJI.200838901

21 January 2018

https://api.crossref.org/works/10.1002%2FEJI.200838901

7 January 2021

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

Monoclonal antibodies targeted against melanoma and ovarian tumors enhance dendritic cell-mediated cross-presentation of tumor-associated antigens and efficiently cross-prime CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

7 January 2021

Redundancy of direct priming and cross-priming in tumor-specific CD8+ T cell responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

7 January 2021

Decreased tumor surveillance after adoptive T-cell therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

7 January 2021

CD8+ T Cell-Dependent Elimination of Dendritic Cells In Vivo Limits the Induction of Antitumor Immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

7 January 2021

Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

7 January 2021

Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

7 January 2021

A comparison of efficacy and specificity of three NK depleting antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838901

7 January 2021

Identifiers

DOI

10.1002/EJI.200838901

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19189311%20AND%20SRC:MED&resulttype=core&format=json

release_vblxm6hd3zb6jfjvwosp6n7cfm

20 January 2020

Fatcat ID

0 references

1 reference